<DOC>
	<DOCNO>NCT02933658</DOCNO>
	<brief_summary>A non-randomized , two-arm , single-sequence , crossover , open label , multiple oral dose clinical trial evaluate safety pharmacokinetic drug-drug interaction Telmisartan/Amlodipine Rosuvastatin healthy male volunteer</brief_summary>
	<brief_title>Study Multiple Oral Dosing Evaluate Safety Pharmacokinetic Drug-drug Interaction Telmisartan/Amlodipine Rosuvastatin Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male â‰¥19 , &lt; 50 year old Man weight 55kg whose BMI 18~30 ( kg/m2 ) Man n't chronic disease history disease man clinically relevant disease liver , kidney , nervous/respiratory/musculoskeletal/cardiovascular/hematooncology system neuropsychiatry</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>